» Articles » PMID: 11701490

Nucleic Acid Biotechnology

Overview
Publisher Annual Reviews
Date 2001 Nov 10
PMID 11701490
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Driven by advances in the acquisition of genetic sequence information and the ability to manipulate small quantities of nucleic acid, a number of technologies are emerging that exploit nucleic acids for research, diagnostic, and therapeutic utility. In this review, we cover three technologies based on nucleic acids--DNA microarrays, antisense technology, and gene therapy--that are especially promising and may make a substantial impact in the laboratory and in the clinic during the coming years. For each of these areas, an overview of the current status and applications is provided, followed by a discussion of critical issues and challenges to be faced for further advancement of the technology; an emphasis is placed on quantitative and engineering aspects.

Citing Articles

Ionic-Liquid-Mediated Extraction and Separation Processes for Bioactive Compounds: Past, Present, and Future Trends.

Ventura S, E Silva F, Quental M, Mondal D, Freire M, Coutinho J Chem Rev. 2017; 117(10):6984-7052.

PMID: 28151648 PMC: 5447362. DOI: 10.1021/acs.chemrev.6b00550.


Improved synthesis strategy for peptide nucleic acids (PNA) appropriate for cell-specific fluorescence imaging.

Pipkorn R, Wiessler M, Waldeck W, Hennrich U, Nokihara K, Beining M Int J Med Sci. 2012; 9(1):1-10.

PMID: 22211082 PMC: 3222083. DOI: 10.7150/ijms.9.1.


Charged polymers modulate retrovirus transduction via membrane charge neutralization and virus aggregation.

Davis H, Rosinski M, Morgan J, Yarmush M Biophys J. 2004; 86(2):1234-42.

PMID: 14747357 PMC: 1303915. DOI: 10.1016/S0006-3495(04)74197-1.


Thermodynamic and kinetic characterization of antisense oligodeoxynucleotide binding to a structured mRNA.

Walton S, Stephanopoulos G, Yarmush M, Roth C Biophys J. 2001; 82(1 Pt 1):366-77.

PMID: 11751323 PMC: 1302476. DOI: 10.1016/S0006-3495(02)75401-5.